Shu-Chen Lyu

Shu-Chen Lyu

Auto-generated profile, based on publicly available information

Shu-Chen Lyu

Sean N. Parker Center for Allergy and Asthma Research Stanford University Stanford CA USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2020 in Allergy
Verified
Journal Article
Open access
PDF file
SGSophie Goyard
Sophie Goyard
BBBianca Balbino
Bianca Balbino
SCSharon R. Chinthrajah
Sharon R. Chinthrajah
SLShu‐Chen Lyu
Shu‐Chen Lyu
YJYves L. Janin
Yves L. Janin
TRThierry Rose
Thierry Rose
Click on the article title to read more.

12 January 2020 in Allergy
Verified
Journal Article
Open access
PDF file
SLSonia Luce
Sonia Luce
SCSharon R. Chinthrajah
Sharon R. Chinthrajah
SLShu-Chen Lyu
Shu-Chen Lyu
Kari NadeauKari Nadeau
Kari Nadeau
LMLaurent Mascarell
Laurent Mascarell
Click on the article title to read more.

4 May 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
XZXiaoying Zhou
Xiaoying Zhou
WYWong Yu
Wong Yu
SLShu-Chen Lyu
Shu-Chen Lyu
CMClaudia Macaubas
Claudia Macaubas
BBBryan Bunning
Bryan Bunning
Kari NadeauKari Nadeau
Kari Nadeau
Food allergies are a leading cause of anaphylaxis, and cellular mechanisms involving antigen presentation likely play key roles in their pathogenesis. However, little is known about the response of specific antigen-presenting cell (APC) subsets to food allergens in the setting of food allergies. Here, we show that in peanut-allergic humans, peanut allergen drives the differentiation of CD209+ monocyte-derived dendritic cells (DCs) and CD23+ (FcєRII) myeloid dendritic cells through the action of allergen-specific CD4+ T cells. CD209+ DCs act reciprocally on the same peanut-specific CD4+ T cell population to reinforce Th2 cytokine expression in a positive feedback loop, which may explain the persistence of established food allergy. In support of this novel model, we show clinically that the initiation of oral immunotherapy (OIT) in peanut-allergic patients is associated with a decrease in CD209+ DCs, suggesting that breaking the cycle of positive feedback is associated with therapeutic effect.